Sympathetic Augmentation in Hypertension: Role of Nerve Firing, Norepinephrine Reuptake, and Angiotensin Neuromodulation

Hypertension

Volumn 43, Issue 2 I, 2004, Pages 169-175

  Schlaich, Markus P ^a   Lambert, Elisabeth ^b   Kaye, David M ^b   Krozowski, Zygmunt ^b   Campbell, Duncan J ^b   Lambert, Gavin ^b   Hastings, Jacqui ^b   Aggarwal, Anuradha ^b   Esler, Murray D ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Angiotensin II; Catecholamines; Hypertension, essential; Norepinephrine; Sympathetic nervous system

Indexed keywords

ANGIOTENSIN; DESIPRAMINE; DNA; NORADRENALIN; NORADRENALIN TRANSPORTER; TRACER;

ADRENERGIC SYSTEM; ADULT; ANGIOTENSIN BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY SINUS; DNA SEQUENCE; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MALE; MUSCLE INNERVATION; NERVE CONDUCTION; NEUROMODULATION; NORADRENALIN RELEASE; NORADRENALIN UPTAKE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; SYMPATHETIC TONE;

ACTION POTENTIALS; ADRENERGIC UPTAKE INHIBITORS; ADULT; ANGIOTENSIN II; BIOLOGICAL TRANSPORT; DESIPRAMINE; FEMALE; HUMANS; HYPERTENSION; MALE; NEURONS; NOREPINEPHRINE; SYMPATHETIC NERVOUS SYSTEM;

EID: 0842289476     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000103160.35395.9E     Document Type: Article

References (23)

1. Anderson EA, Sinkey CA, Lawton WJ, Mark AL. Elevated sympathetic nerve activity in borderline hypertensive humans: evidence from direct intraneural recordings. Hypertension. 1989;14:177-183.
2. Grassi G, Colombo M, Seravalle G, Spaziani D, Mancia G. Dissociation between muscle and skin sympathetic nerve activity in essential hypertension, obesity, and congestive heart failure. Hypertension. 1998;31: 64-67.
3. Esler M, Jackman G, Bobik A, Leonard P, Kelleher D, Skews H, Jennings G, Korner P. Norepinephrine kinetics in essential hypertension: defective neuronal uptake of norepinephrine in some patients. Hypertension. 1981; 3:149-156.
4. Rumantir MS, Kaye DM, Jennings GL, Vaz M, Hastings JA, Esler MD. Phenotypic evidence of faulty neuronal norepinephrine reuptake in essential hypertension. Hypertension. 2000;36:824-829.
5. Matsukawa T, Gotoh E, Hasegawa O, Shionoiri H, Tochikubo O, Ishii M. Reduced baroreflex changes in muscle sympathetic nerve activity during blood pressure elevation in essential hypertension. J Hypertens. 1991;9: 537-542.
6. Perondi R, Saino A, Tio RA, Pomidossi G, Gregorini L, Alessio P, Morganti A, Zanchetti A, Mancia G. ACE inhibition attenuates sympathetic coronary vasoconstriction in patients with coronary artery disease. Circulation. 1992;85:2004-2013.
7. Esler MD, Wallin G, Dorward PK, Eisenhofer G, Westerman R, Meredith I, Lambert G, Cox HS, Jennings G. Effects of desipramine on sympathetic nerve firing and norepinephrine spillover to plasma in humans. Am J Physiol. 1991;260:R817-R823.
8. Runkel F, Bruss M, Nothen MM, Stober G, Propping P, Bonisch H. Pharmacological properties of naturally occurring variants of the human norepinephrine transporter. Pharmacogenetics. 2000;10:397-405.
9. Danser AH, van Kats JP, Verdouw PD, Schalekamp MA. Evidence for the existence of a functional cardiac renin-angiotensin system in humans. Circulation. 1997;96:3795-3796.
10. 1999 World Health Organization. International Society of Hypertension Guidelines for the Management of Hypertension: Guidelines Subcommittee. J Hypertens. 1999;17:151-183.
11. Sundlof G, Wallin BG. Human muscle nerve sympathetic activity at rest: relationship to blood pressure and age. J Physiol. 1978;274:621-637.
12. Lambert EA, Thompson J, Schlaich M, Laude D, Elghozi JL, Esler MD, Lambert GW. Sympathetic and cardiac baroreflex function in panic disorder. J Hypertens. 2002;20:2445-2451.
13. Esler M, Jennings G, Lambert G, Meredith I, Horne M, Eisenhofer G. Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol Rev. 1990;70:963-985.
14. Eisenhofer G, Goldstein DS, Stull R, Keiser HR, Sunderland T, Murphy DL, Kopin IJ. Simultaneous liquid-chromatographic determination of 3, 4-dihydroxyphenylglycol, catecholamines, and 3, 4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clin Chem. 1986;32:2030-2033.
15. Lawrence AC, Evin G, Kladis A, Campbell DJ. An alternative strategy for the radioimmunoassay of angiotensin peptides using amino-terminal-directed antisera: measurement of eight angiotensin peptides in human plasma. J Hypertens. 1990;8:715-724.
16. Runkel F, Bruss M, Nothen MM, Stober G, Propping P, Bonisch H. Pharmacological properties of naturally occurring variants of the human norepinephrine transporter. Pharmacogenetics. 2000;10:397-405.
17. Stober G, Nothen MM, Porzgen P, Bruss M, Bonisch H, Knapp M, Beckmann H, Propping P. Systematic search for variation in the human norepinephrine transporter gene: identification of five naturally occurring missense mutations and study of association with major psychiatric disorders. Am J Med Genet. 1996;67:523-532.
18. Esler M, Ferrier C, Lambert G, Eisenhofer G, Cox H, Jennings G. Biochemical evidence of sympathetic hyperactivity in human hypertension. Hypertension. 1991;17(suppl III):III-29-III-35.
19. Esler M, Jackman G, Bobik A, Kelleher D, Jennings G, Leonard P, Skews H, Korner P. Determination of norepinephrine apparent release rate and clearance in humans. Life Sci. 1979;25:1461-1470.
20. Rea RF, Hamdan M. Baroreflex control of muscle sympathetic nerve activity in borderline hypertension. Circulation. 1990;82:856-862.
21. Grassi G, Cattaneo BM, Seravalle G, Lanfranchi A, Mancia G. Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. Hypertension. 1998;31:68-72.
22. Raasch W, Betge S, Dendorfer A, Bartels T, Dominiak P. Angiotensin converting enzyme inhibition improves cardiac neuronal uptake of noradrenaline in spontaneously hypertensive rats. J Hypertens. 2001;19: 1827-1833.
23. Rundqvist B, Eisenhofer G, Emanuelsson H, Albertsson P, Friberg P. Intracoronary blockade of angiotensin-converting enzyme in humans: interaction with cardiac sympathetic neurotransmission? Acta Physiol Scand. 1997;161:15-22.